NCT03372629 - A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 12, 2018

Primary Completion Date

December 2, 2018

Study Completion Date

December 2, 2018

Conditions

Healthy Subjects

Interventions

DRUG

ID-085

Hard gelatin capsules for oral administration formulated in strengths of 10 mg, 100 mg, and 200 mg

DRUG

Placebo oral capsule

Placebo capsules matching ID-085 capsules

Trial Locations (1)

Covance Clinical Research Unit - Clinical Pharmacology Services, Leeds